Philip K Chan

3PUBLICATIONS
16CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Feb 24, 2026
Real-world outcomes after CAR T versus standard therapy in third-line or later relapsed or refractory follicular lymphoma in the United States.

Philip K Chan, Markqayne Ray, Karl M Kilgore

|Feb 04, 2026
Healthcare resource utilization, costs, and survival among Medicare beneficiaries with relapsed or refractory DLBCL receiving second-line therapy: a real-world evidence study.

Mugdha Gokhale, Philip K Chan, Wei Jiang

|Nov 14, 2023
Real-world outcomes of 18,186 metastatic solid tumor outpatients: Baseline blood cell counts correlate with survival after immune checkpoint inhibitor therapy.

Jerome H Goldschmidt, Lin-Na Chou, Philip K Chan

Pageof 1

Frequent Collaborators

1 joint publications

Lin-Na Chou

1 joint publications

Joyce Kinsey

1 joint publications

Katherine Pitts

1 joint publications

Matt Nestor